Literature DB >> 14746830

Barrett's esophagus.

Jeffrey H Peters1, Jeffrey A Hagen, Steven R DeMeester.   

Abstract

Mesh：

Year:  2004        PMID： 14746830     DOI： 10.1016/s1091-255x(03)00136-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  99 in total

1.  Is there a "Barrett's iceberg?".

Authors:  Nicholas Shaheen
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

2.  Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure.

Authors:  V N Shirvani; R Ouatu-Lascar; B S Kaur; M B Omary; G Triadafilopoulos
Journal:  Gastroenterology       Date:  2000-03       Impact factor: 22.682

3.  Assessment of proliferation of squamous, Barrett's and gastric mucosa in patients with columnar lined Barrett's oesophagus.

Authors:  S Y Iftikhar; R J Steele; S Watson; P D James; K Dilks; J D Hardcastle
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

4.  Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study.

Authors:  R E Sampliner; D Faigel; M B Fennerty; D Lieberman; A Ippoliti; K Lewin; W M Weinstein
Journal:  Gastrointest Endosc       Date:  2001-05       Impact factor: 9.427

5.  P53 gene protein overexpression predicts results of trimodality therapy in esophageal cancer patients.

Authors:  M J Krasna; Y S Mao; J R Sonett; G Tamura; R Jones; M Suntharalingam; S J Meltzer
Journal:  Ann Thorac Surg       Date:  1999-12       Impact factor: 4.330

Review 6.  Role of p53 assessment in management of Barrett's esophagus.

Authors:  A K Kubba; N A Poole; A Watson
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

7.  Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation.

Authors:  T Bailey; L Biddlestone; N Shepherd; H Barr; P Warner; J Jankowski
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

8.  Barrett's oesophagus: effect of antireflux surgery on symptom control and development of complications.

Authors:  S E Attwood; A P Barlow; T L Norris; A Watson
Journal:  Br J Surg       Date:  1992-10       Impact factor: 6.939

9.  Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.

Authors:  D A Katzka; D O Castell
Journal:  Am J Gastroenterol       Date:  1994-07       Impact factor: 10.864

10.  Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.

Authors:  W K Hirota; T M Loughney; D J Lazas; C L Maydonovitch; V Rholl; R K Wong
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682
View more
  9 in total

Review 1.  Guidelines for surgical treatment of gastroesophageal reflux disease.

Authors:  Dimitrios Stefanidis; William W Hope; Geoffrey P Kohn; Patrick R Reardon; William S Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

Review 2.  Current management of esophageal cancer.

Authors:  Simon Law; John Wong
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

3.  Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett's adenocarcinoma.

Authors:  Hidekazu Kuramochi; Daniel Vallböhmer; Kazumi Uchida; Sylke Schneider; Nahid Hamoui; Daisuke Shimizu; Parakrama T Chandrasoma; Tom R DeMeester; Kathleen D Danenberg; Peter V Danenberg; Jeffrey H Peters
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

4.  Significance of Nissen fundoplication after endoscopic radiofrequency ablation of Barrett's esophagus.

Authors:  Ognjan Skrobić; Aleksandar Simić; Nebojša Radovanović; Nenad Ivanović; Marjan Micev; Predrag Peško
Journal:  Surg Endosc       Date:  2015-12-10       Impact factor: 4.584

5.  COX-2 mRNA expression is significantly increased in acid-exposed compared to nonexposed squamous epithelium in gastroesophageal reflux disease.

Authors:  Georg Lurje; Daniel Vallbohmer; Peter H Collet; Huan Xi; Stephan E Baldus; Jan Brabender; Ralf Metzger; Michaela Heitmann; Susanne Neiss; Ute Drebber; Arnulf H Holscher; Paul M Schneider
Journal:  J Gastrointest Surg       Date:  2007-07-10       Impact factor: 3.452

6.  Management of oesophageal cancer.

Authors:  Daniel K H Tong; Simon Law
Journal:  Indian J Surg       Date:  2010-01-13       Impact factor: 0.656

7.  Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system.

Authors:  C D Smith; P A Bejarano; W S Melvin; M G Patti; R Muthusamy; B J Dunkin
Journal:  Surg Endosc       Date:  2006-12-16       Impact factor: 3.453

8.  Cellular basis of urothelial squamous metaplasia: roles of lineage heterogeneity and cell replacement.

Authors:  Feng-Xia Liang; Maarten C Bosland; Hongying Huang; Rok Romih; Solange Baptiste; Fang-Ming Deng; Xue-Ru Wu; Ellen Shapiro; Tung-Tien Sun
Journal:  J Cell Biol       Date:  2005-12-05       Impact factor: 10.539

9.  Ki-67 Antigen Overexpression Is Associated with the Metaplasia-Adenocarcinoma Sequence in Barrett's Esophagus.

Authors:  Bernardo Silveira Volkweis; Richard Ricachenevsky Gurski; Luise Meurer; Guilherme Gonçalves Pretto; Guilherme da Silva Mazzini; Maria Isabel Edelweiss
Journal:  Gastroenterol Res Pract       Date:  2012-07-11       Impact factor: 2.260
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.